Literature DB >> 2775784

Serum opsonins and phagocytosis of saturated and unsaturated phospholipid liposomes.

S M Moghimi1, H M Patel.   

Abstract

Recently we reported that serum contains opsonins specific for hepatic and splenic phagocytic cells and that these opsonins have different properties and affinities for cholesterol-rich and cholesterol-free egg phosphatidylcholine liposomes (Moghimi, S.M. and Patel, H.M. (1988) FEBS Lett. 233, 143-147). In the present report we investigate the affinity of these opsonins for the liposomes prepared from sphingomyelin and saturated phospholipids, as measured by their effect on the uptake of these liposomes by hepatic and splenic phagocytic cells. Results presented here suggest that neither liver- nor spleen-specific opsonins have affinity for sphingomyelin or saturated phospholipid liposomes since serum fails to enhance their uptake in liver or splenic cells. On the contrary, these liposomes attract serum dysopsonins which inhibit their uptake by liver cells. Inclusion of cholesterol in these liposome preparations enhances their uptake in splenic cells but not in liver cells. It is suggested that fluidity and hydrophobicity of liposomal membranes play an important role in attracting the right opsonins which determine their phagocytic fate.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2775784     DOI: 10.1016/0005-2736(89)90307-6

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  12 in total

Review 1.  Magnetic resonance molecular imaging with nanoparticles.

Authors:  Gregory M Lanza; Patrick M Winter; Shelton D Caruthers; Anne M Morawski; Anne H Schmieder; Katherine C Crowder; Samuel A Wickline
Journal:  J Nucl Cardiol       Date:  2004 Nov-Dec       Impact factor: 5.952

2.  Dysopsonin activity of serum DNA-binding proteins favorable for gene delivery.

Authors:  Feng Liu; Amber Frick; Xing Yuan; Leaf Huang
Journal:  J Pharmacol Exp Ther       Date:  2009-10-28       Impact factor: 4.030

Review 3.  Nanocarriers for spleen targeting: anatomo-physiological considerations, formulation strategies and therapeutic potential.

Authors:  Anil B Jindal
Journal:  Drug Deliv Transl Res       Date:  2016-10       Impact factor: 4.617

Review 4.  Drug delivery trends in clinical trials and translational medicine: challenges and opportunities in the delivery of nucleic acid-based therapeutics.

Authors:  Long Xu; Thomas Anchordoquy
Journal:  J Pharm Sci       Date:  2011-01       Impact factor: 3.534

5.  Distinction between the depletion of opsonins and the saturation of uptake in the dose-dependent hepatic uptake of liposomes.

Authors:  H Harashima; K Sakata; H Kiwada
Journal:  Pharm Res       Date:  1993-04       Impact factor: 4.200

6.  Monosialoganglioside GM1 shortens the blood circulation time of liposomes in rats.

Authors:  D Liu; F Liu; Y K Song
Journal:  Pharm Res       Date:  1995-04       Impact factor: 4.200

7.  Polystyrene-poly (ethylene glycol) (PS-PEG2000) particles as model systems for site specific drug delivery. 2. The effect of PEG surface density on the in vitro cell interaction and in vivo biodistribution.

Authors:  S E Dunn; A Brindley; S S Davis; M C Davies; L Illum
Journal:  Pharm Res       Date:  1994-07       Impact factor: 4.200

8.  Contact activation of kallikrein-kinin system by superparamagnetic iron oxide nanoparticles in vitro and in vivo.

Authors:  Dmitri Simberg; Wan-Ming Zhang; Sergei Merkulov; Keith McCrae; Ji-Ho Park; Michael J Sailor; Erkki Ruoslahti
Journal:  J Control Release       Date:  2009-06-07       Impact factor: 9.776

Review 9.  Analysing the nanoparticle-protein corona for potential molecular target identification.

Authors:  Chandra Kumar Elechalawar; Md Nazir Hossen; Lacey McNally; Resham Bhattacharya; Priyabrata Mukherjee
Journal:  J Control Release       Date:  2020-03-09       Impact factor: 9.776

Review 10.  Clinical applications of perfluorocarbon nanoparticles for molecular imaging and targeted therapeutics.

Authors:  Trung D Tran; Shelton D Caruthers; Michael Hughes; John N Marsh; Tillmann Cyrus; Patrick M Winter; Anne M Neubauer; Samuel A Wickline; Gregory M Lanza
Journal:  Int J Nanomedicine       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.